One Day In July LLC Has $422,000 Position in Danaher Co. (NYSE:DHR)

One Day In July LLC lessened its position in Danaher Co. (NYSE:DHR) by 43.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,837 shares of the conglomerate’s stock after selling 1,413 shares during the quarter. One Day In July LLC’s holdings in Danaher were worth $422,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Heck Capital Advisors LLC acquired a new stake in Danaher in the 4th quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new stake in Danaher in the 4th quarter valued at approximately $31,000. Golden State Wealth Management LLC acquired a new stake in Danaher in the 4th quarter valued at approximately $31,000. Strategic Financial Concepts LLC acquired a new stake in Danaher in the 4th quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC raised its position in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on DHR shares. Guggenheim started coverage on Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Wells Fargo & Company lowered their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Citigroup lowered their price target on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 30th. Finally, Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research report on Thursday, October 31st. Seven equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Stock Performance

DHR opened at $208.10 on Friday. The business has a fifty day simple moving average of $227.21 and a 200 day simple moving average of $247.52. The company has a market capitalization of $150.31 billion, a PE ratio of 39.41, a price-to-earnings-growth ratio of 2.61 and a beta of 0.83. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the firm posted $2.09 earnings per share. Research analysts expect that Danaher Co. will post 7.67 EPS for the current year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher’s payout ratio is 20.45%.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.